Validation of Recursive Partitioning Analysis Classification in Patients with Brain Metastases from Non-small Cell Lung Cancer Treated with Short-course Accelerated Radiotherapy

Clinical Oncology

Volumn 22, Issue 10, 2010, Pages 837-843

  Agarwal, J P ^a   Wadasadawala, T ^a   Munshi, A ^a   Chadda, P ^a   Apsani, R ^a   Upasani, M ^a   Laskar, S G ^a   Pramesh, C S ^a   Karimundackal, G ^a   Menon, H ^a   Prabhash, K ^a   Jambhekar, N ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Brain metastases; Non small cell lung cancer; Recursive partitioning analysis; Short course radiotherapy

Indexed keywords

ADULT; ARTICLE; BRAIN METASTASIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POPULATION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; SHORT COURSE ACCELERATED RADIOTHERAPY; SURVIVAL RATE; SYSTEMIC THERAPY; TREATMENT OUTCOME; VALIDATION STUDY;

ADULT; AGED; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 78149499819     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2010.05.022     Document Type: Article

References (23)

1. Parkin D.M., Bray F., Pisani P., Ferlay J. Global cancer statistics. CA Cancer J Clin 2002, 2005(55):74-108.
2. Delattre J.Y., Krol G., Thaler H.T., Posner J.B. Distribution of brain metastases. Arch Neurol 1988, 45:741-744.
3. Mamon H.J., Yeap B.Y., Jänne P.A., et al. High risk of brain metastases in surgically staged IIIA non-small cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol 2005, 23:1530-1537.
4. Tsao M.N., Lloyd N., Wong R., Chow E., Rakovitch E., Laperriere N. Whole brain radiotherapy for the treatment of multiple brain metastases. Cochrane Database Syst Rev 2006, 3. CD003869.
5. Rades D., Schild S.E., Lohynska R., Veninga T., Stalpers L.J.A., Dunst J. Two radiation regimens and prognostic factors for brain metastases in non small cell lung cancer patients. Cancer 2007, 110:1077-1082.
6. Rades D., Bohlen G., Dunst J., et al. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases. Strahlenther Onkol 2008, 184:30-35.
7. Singh N., Aggarwal A.N., Gupta D., Behera D., Jindal S.K. Unchanging clinico-epidemiological profile of lung cancer in North India over three decades. Cancer Epidemiol 2010, 34:101-104.
8. Sen S., Ateeq B., Sharma H., et al. Molecular profiling of genes in squamous cell lung carcinoma in Asian Indians. Life Sci 2008, 82:772-779.
9. Gaspar L.E., Scott C., Murray K., Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 2000, 47:1001-1006.
10. Bonnette P., Puyo P., Gabriel C., et al. Surgical management of non-small cell lung cancer with synchronous brain metastases. Chest 2001, 119:1469-1475.
11. Louie A.V., Rodrigues G., Yaremko B., et al. Management and prognosis in synchronous solitary resected brain metastasis from non-small-cell lung cancer. Clin Lung Cancer 2009, 10:174-179.
12. Videtic G.M., Reddy C.A., Chao S.T., et al. Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the Radiation Therapy Oncology Group Recursive Partitioning Analysis classification. Int J Radiat Oncol Biol Phys 2009, 75:1141-1147.
13. Gaspar L., Scott C., Rotman M., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745-751.
14. Kepka L., Cieslak E., Bujko K., Fijuth J., Wierzchowski M. Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis. Acta Oncol 2005, 44:389-398.
15. Jacot W., Quantin X., Boher J.M., et al. Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors. Br J Cancer 2001, 84:903-909.
16. Robin E., Bitran J.D., Golomb H.M., et al. Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastases. Cancer 1982, 49:1916-1919.
17. Novello S., Vavala' T. Lung cancer and women. Future Oncol 2008, 4:705-716.
18. Kim K.H., Lee J., Lee J.I., et al. Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?. Lung Cancer 2010, 68:258-263.
19. Oh Y., Taylor S., Bekele B.N., et al. Number of metastatic sites is a strong predictor of survival in patients with non small cell lung cancer with or without brain metastases. Cancer 2009, 115:2930-2938.
20. Andrews D.W., Scott C.B., Sperduto P.W., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomized trial. Lancet 2004, 363:1665-1672.
21. Zabel A., Milker-Zabel S., Thilmann C., et al. Treatment of brain metastases in patients with non-small cell lung cancer (NSCLC) by stereotactic linac-based radiosurgery: prognostic factors. Lung Cancer 2002, 37:87-94.
22. Flannery T.W., Suntharalingam M., Kwok Y., et al. Gamma knife stereotactic radiosurgery for synchronous versus metachronous solitary brain metastases from non-small cell lung cancer. Lung Cancer 2003, 42:327-333.
23. Fukuoka M., Yano S., Giaccone G., et al. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer. (The IDEAL 1 Trial). J Clin Oncol 2003, 21:2237-2246. [corrected].